A Phase I, Single Centre, Randomised, Double-blind, Placebo-controlled Study to Assess the Safety, Tolerability and Pharmacokinetics of a Single Dose and Multiple Doses of TC-5214 (S-Mecamylamine) in Healthy Male Japanese Subjects

Trial Profile

A Phase I, Single Centre, Randomised, Double-blind, Placebo-controlled Study to Assess the Safety, Tolerability and Pharmacokinetics of a Single Dose and Multiple Doses of TC-5214 (S-Mecamylamine) in Healthy Male Japanese Subjects

Completed
Phase of Trial: Phase I

Latest Information Update: 05 Feb 2013

At a glance

  • Drugs Dexmecamylamine (Primary)
  • Indications Anxiety disorders; Depression
  • Focus Adverse reactions
  • Most Recent Events

    • 07 Dec 2010 Actual end date (Jul 2010) added as reported by ClinicalTrials.gov.
    • 07 Dec 2010 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov.
    • 18 Aug 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top